NRC News and Press, National Research Corporation From 01/18/23

MALVERN, Pa., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the grantin...

MALVERN, Pa., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced a new p...

MALVERN, Pa., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it has...

MALVERN, Pa., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced certain pre...

National Research Corporation (NRC) Q3 2022 Earnings Conference Call November 03, 2022 10:00 AM ET Company Participants Linda Stacy - VP, Finance Kevin Karas - Chief Financial Officer Conference Call Participants George D'Angelo - Alpine Peaks Capital ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors may want to target small-cap stocks to buy. Understandably, smaller and therefore less-proven enterprises present higher risks, which is why some folks avoid the sector. Nevertheless, because they’re so sma...

National Research press release ( NASDAQ: NRC ): Q3 GAAP EPS of $0.33. Revenue of $37.7M (-0.2% Y/Y). For further details see: National Research GAAP EPS of $0.33, revenue of $37.7M

National Research press release ( NASDAQ: NRC ): Q3 GAAP EPS of $0.33. Revenue of $37.69M (-0.2% Y/Y). For further details see: National Research GAAP EPS of $0.33, revenue of $37.69M

LINCOLN, Neb., Nov. 01, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2022. Regarding the Company’s 2022 third quarter financial performance, Kevin Karas, Chief Financial Officer, said, “...

Trust in individual healthcare providers depends largely on patients’ language preferences U.S. counties where provider trust is highest and lowest are politically mixed LINCOLN, Neb., Nov. 01, 2022 (GLOBE NEWSWIRE) -- NRC Health , the leading partner in bui...